{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:35:43Z","timestamp":1770824143082,"version":"3.50.1"},"reference-count":22,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A real-time PCR assay was developed to quantify human cytomegalovirus (CMV) DNA in peripheral blood leukocytes (PBLs) of bone marrow transplantation patients. Unlike other teams, we quantified CMV and the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene using a plasmid containing both sequences as an external standard. Tenfold serial dilutions of this plasmid yielded overlapping standard curves that allowed the quantification of CMV and GAPDH gene copies in an efficient and accurate manner. Sequential blood samples (164 specimens) were collected from 16 patients. PBLs were tested by the pp65 antigenemia assay and quantitative CMV and GAPDH gene PCRs. CMV DNA was detected by PCR in 13 patients a mean of 15 days prior to the appearance of antigenemia. The administration of anti-CMV drugs led to a rapid decrease in the numbers of viral copies and positive nuclei. Real-time PCR assay results correlated with those of the CMV pp65 antigenemia assay (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.00001). The TaqMan assay may be a useful tool for rapid quantification of CMV infection and for monitoring of CMV reactivation in bone marrow transplantation recipients.\n          <\/jats:p>","DOI":"10.1128\/jcm.39.12.4362-4369.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:23Z","timestamp":1027764383000},"page":"4362-4369","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":95,"title":["Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR"],"prefix":"10.1128","volume":"39","author":[{"given":"Frank","family":"Griscelli","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Service de Microbiologie,1"}]},{"given":"Michel","family":"Barrois","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Service de Ge\u0301ne\u0301tique Mole\u0301culaire,2"}]},{"given":"Sylvie","family":"Chauvin","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Service de Microbiologie,1"}]},{"given":"Stephane","family":"Lastere","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Service de Microbiologie,1"}]},{"given":"Dominique","family":"Bellet","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Service d'Immunologie,3 and"}]},{"given":"Jean-Henri","family":"Bourhis","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Service d'He\u0301matologie Oncologique,4 Institut Gustave-Roussy, 94805 Villejuif Cedex, France"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.2.563-569.2000"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.5.1104.1104"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700941"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.2.772-775.2001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.6.1236"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.19.6.917-919.1984"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112053252303"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-3-199302010-00003"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.5.1333-1337.1998"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1752987.x"},{"key":"e_1_3_2_13_2","first-page":"583","article-title":"Use of a semiquantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients","volume":"17","author":"Ljungman P.","year":"1996","unstructured":"Ljungman P. Lore K. Aschan J. Klaesson S. Lewensohn-Fuchs I. Lonnqvist B. Ringden O. Winiarski J. Ehrnst A. Use of a semiquantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.Bone Marrow Transplant.171996583587","journal-title":"Bone Marrow Transplant."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.7.2536-2542.2000"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<251::AID-JMV12>3.0.CO;2-X"},{"key":"e_1_3_2_16_2","first-page":"95","article-title":"Cytomegalovirus antigenemia assay: therapeutic usefulness and biological significance","volume":"35","author":"Perol Y.","year":"1993","unstructured":"Perol Y. Caro V. Mazeron M. C. Cytomegalovirus antigenemia assay: therapeutic usefulness and biological significance.Nouv. Rev. Fr. Hematol.3519939598","journal-title":"Nouv. Rev. Fr. Hematol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.3.473"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104113241501"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701354"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<455::AID-JMV14>3.0.CO;2-Q"},{"key":"e_1_3_2_21_2","first-page":"S734","article-title":"Cytomegalovirus antigenemia","volume":"12","author":"The T. H.","year":"1990","unstructured":"The T. H. Van der Bij W. Van den Berg A. P. Van der Giessen M. Weits J. Sprenger H. G. Van Son W. J. Cytomegalovirus antigenemia.Rev. Infect. Dis.12 (Suppl. 7)1990S734S744","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890430217"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200004270-00037"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.12.4362-4369.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.12.4362-4369.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:55:53Z","timestamp":1646441753000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.39.12.4362-4369.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1128\/JCM.39.12.4362-4369.2001"],"URL":"https:\/\/doi.org\/10.1128\/jcm.39.12.4362-4369.2001","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]},"assertion":[{"value":"2001-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-09-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}